Scholarly Index
Mark Topazian
Mayo Clinic; 18,665 total citations; 468 total publications; best world rank #88
Mayo Clinic
18,665Total citations
468Total publications
69H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Gallbladder and Bile Duct Disorders | Lifetime | 88 | US 36 | 99.43 |
| Gastrointestinal disorders and treatments | Lifetime | 97 | US 42 | 99.46 |
| Pancreatitis Pathology and Treatment | Lifetime | 107 | US 51 | 99.28 |
| Pancreatic and Hepatic Oncology Research | Lifetime | 280 | US 140 | 99.18 |
| Pediatric Hepatobiliary Diseases and Treatments | Lifetime | 124 | US 53 | 99.08 |
| Esophageal and GI Pathology | Lifetime | 297 | US 144 | 98.87 |
| Neuroendocrine Tumor Research Advances | Lifetime | 636 | US 260 | 97.93 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | Lifetime | 668 | US 187 | 97.51 |
| IgG4-Related and Inflammatory Diseases | Lifetime | 134 | US 37 | 95.46 |
| Biliary and Gastrointestinal Fistulas | Lifetime | 750 | US 259 | 91.11 |
| Pancreatitis Pathology and Treatment | 2021-2025 | 388 | US 89 | 93.01 |
| Gallbladder and Bile Duct Disorders | 2021-2025 | 890 | US 174 | 88.19 |